EXoZymes Common Stock from 2010 to 2026

EXOZ Stock   10.22  0.22  2.20%   
EXoZymes Common Stock yearly trend continues to be fairly stable with very little volatility. Common Stock will likely drop to 6.40 in 2026. During the period from 2010 to 2026, EXoZymes Common Stock regression line of annual values had r-squared of  0.59 and arithmetic mean of  10.45. View All Fundamentals
 
Common Stock  
First Reported
2010-12-31
Previous Quarter
7.2
Current Value
6.4
Quarterly Volatility
2.51746838
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check EXoZymes financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXoZymes' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 93.7 K or Interest Income of 72.6, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 15.54. EXoZymes financial statements analysis is a perfect complement when working with EXoZymes Valuation or Volatility modules.
  
Build AI portfolio with EXoZymes Stock
Check out the analysis of EXoZymes Correlation against competitors.
For more information on how to buy EXoZymes Stock please use our How to Invest in EXoZymes guide.
The evolution of Common Stock for eXoZymes provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how EXoZymes compares to historical norms and industry peers.

Latest EXoZymes' Common Stock Growth Pattern

Below is the plot of the Common Stock of eXoZymes over the last few years. It is EXoZymes' Common Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EXoZymes' overall financial position and show how it may be relating to other accounts over time.
Common Stock10 Years Trend
Slightly volatile
   Common Stock   
       Timeline  

EXoZymes Common Stock Regression Statistics

Arithmetic Mean10.45
Geometric Mean10.10
Coefficient Of Variation24.10
Mean Deviation2.19
Median12.00
Standard Deviation2.52
Sample Variance6.34
Range6.0
R-Value(0.77)
Mean Square Error2.76
R-Squared0.59
Significance0.0003
Slope(0.38)
Total Sum of Squares101.40

EXoZymes Common Stock History

2026 6.4
2025 7.2
2024 8.0
2022 6.0

Other Fundumenentals of eXoZymes

EXoZymes Common Stock component correlations

About EXoZymes Financial Statements

EXoZymes investors use historical fundamental indicators, such as EXoZymes' Common Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in EXoZymes. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Shares Outstanding7.3 M6.5 M
Common Stock 7.20  6.40 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for EXoZymes Stock Analysis

When running EXoZymes' price analysis, check to measure EXoZymes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXoZymes is operating at the current time. Most of EXoZymes' value examination focuses on studying past and present price action to predict the probability of EXoZymes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXoZymes' price. Additionally, you may evaluate how the addition of EXoZymes to your portfolios can decrease your overall portfolio volatility.